Heparin Calcium Growth Accelerated By Increased Usage Of Anti-Coagulant Medications

https://www.coherentmarketinsights.com/market-insight/heparin-calcium-market-548
Heparin Calcium Market



Heparin Calcium is used as a blood thinner to prevent unwanted blood clot formation. It finds widespread application in surgical procedures and treatment of various medical conditions such as heart attacks and strokes where blood clots pose life-threatening risks. Heparin Calcium helps extend the life of medical devices such as catheters and reduces complications arising from clot formation.

With an increasing geriatric population susceptible to cardiovascular ailments and rising demand for surgical interventions, the need for anticoagulant medications has grown considerably.

The global Heparin Calcium Market is estimated to be valued at US$ 1407.91 Mn in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increased incidences of diseases requiring anticoagulant therapy and rapid adoption of minimal invasive surgeries have been the key drivers of growth for the Heparin Calcium market. As per statistical reports, cardiovascular diseases caused over 17.3 million deaths in 2008 and this number is expected to reach 23.3 million by 2030. With aging population in major economies, the risk of heart attacks and strokes continues to rise. Additionally, continuous technological advancements have enabled more complex surgeries to be performed using minimal incisions thus driving greater utilization of blood thinners in postsurgical care. All of these factors have contributed to the consistent growth witnessed in the Heparin Calcium market over the recent past.


Segment Analysis
The global heparin calcium market is segmented on the basis of product, form, route of administration, application, end-use, and region. By product, the market is segmented into unfractionated heparin and low molecular weight heparin. The unfractionated heparin segment is dominating the market currently due to its widespread use in surgeries and procedures. However, the low molecular weight heparin segment is expected to grow at a higher CAGR during the forecast period due to its lesser side effects as compared to unfractionated heparin.

Key Takeaways
The global Heparin Calcium Market Size is expected to witness high growth during the forecast period of 2023-2030. The market size is anticipated to grow from US$ 1407.91 million in 2023 to reach US$ 2099.35 million by 2030, expanding at a CAGR of 2.7%.

Regional analysis
North America is currently the largest and fastest growing regional market for heparin calcium. Growth in this region can be attributed to the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases and respiratory disorders. The rising healthcare expenditure, better reimbursement policies and presence of established market players are also supporting market growth in North America.

Key players
Key players operating in the heparin calcium market are Sanofi, Pfizer Inc., Dongying Tiandong Pharmaceutical Co., Ltd., PANPHARMA S.A., Merck KGaA, Teva Pharmaceutical Industries Ltd., SMITHFIELD BIOSCIENCE, Afine Chemicals Limited, Yino Pharma Limited, Shandong Sheelian Pharmaceutical Co., Ltd., Aspen Holdings, Opocrin S.p.A. Sanofi holds the largest market share currently owing to its diverse product portfolio and strong brand presence globally.


Comments

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries